A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or Hemodialysis
This study has been completed.
AbbVie (prior sponsor, Abbott)
First Posted: June 27, 2011
Last Update Posted: November 21, 2016
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )